This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Benn, D. E. Articles by Robinson, B. G. Search for Related Content PubMed PubMed Citation Articles by Benn, D. E. Articles by Robinson, B. G.

Sporadic and Familial Pheochromocytomas Are Associated with Loss of at Least Two Discrete Intervals on Chromosome 1p

Cancer Genetics, Kolling Institute of Medical Research [D. E. B., T. D., A. L. R., D. J. M., B. G. R.] and Department of Surgery [L. D., C. P. B.], Royal North Shore Hospital, St. Leonards, New South Wales 2065; Departments of Medicine [D. E. B., T. D., D. J. M., B. G. R.] and Surgery [L. D.], University of Sydney, New South Wales 2006; and Hypertension Unit, University Department of Medicine, Greenslopes Hospital, Brisbane, Queensland 4120 [M. S., R. D. G.], Australia

Pheochromocytomas are tumors of the adrenal medulla originating in the chromaffin cells derived from the neural crest. Ten % of these tumors are associated with the familial cancer syndromes multiple endocrine neoplasia type 2, von Hippel-Lindau disease (VHL), and rarely, neurofibromatosis type 1, in which germ-line mutations have been identified in RET, VHL, and NF1, respectively. In both the sporadic and familial forms of pheochromocytoma, allelic loss at 1p, 3p, 17p, and 22q has been reported, yet the molecular pathogenesis of these tumors is largely unknown. Allelic loss at chromosome 1p has also been reported in other endocrine tumors, such as medullary thyroid cancer and tumors of the parathyroid gland, as well as in tumors of neural crest origin including neuroblastoma and malignant melanoma. In this study, we performed fine structure mapping of deletions at chromosome 1p in familial and sporadic pheochromocytomas to identify discrete regions likely housing tumor suppressor genes involved in the development of these tumors. Ten microsatellite markers spanning a region of 70 cM (1pter to 1p34.3) were used to screen 20 pheochromocytomas from 19 unrelated patients for loss of heterozygosity (LOH). LOH was detected at five or more loci in 8 of 13 (61%) sporadic samples and at five or more loci in four of five (80%) tumor samples from patients with multiple endocrine neoplasia type 2. No LOH at 1p was detected in pheochromocytomas from two VHL patients. Analysis of the combined sporadic and familial tumor data suggested three possible regions of common somatic loss, designated as PC1 (D1S243 to D1S244), PC2 (D1S228 to D1S507), and PC3 (D1S507 toward the centromere). We propose that chromosome 1p may be the site of at least three putative tumor suppressor loci involved in the tumorigenesis of pheochromocytomas. At least one of these loci, PC2 spanning an interval of <3.8 cM, is likely to have a broader role in the development of endocrine malignancies.

This article has been cited by other articles:

				M. A. Edson, A. K. Nagaraja, and M. M. Matzuk The Mammalian Ovary from Genesis to Revelation Endocr. Rev., October 1, 2009; 30(6): 624 - 712. [Abstract] [Full Text] [PDF]

				S. Schlisio, R. S. Kenchappa, L. C.W. Vredeveld, R. E. George, R. Stewart, H. Greulich, K. Shahriari, N. V. Nguyen, P. Pigny, P. L. Dahia, et al. The kinesin KIF1B{beta} acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor Genes & Dev., April 1, 2008; 22(7): 884 - 893. [Abstract] [Full Text] [PDF]

				X. Song, Y. Sun, and A. Garen From The Cover: Roles of PSF protein and VL30 RNA in reversible gene regulation PNAS, August 23, 2005; 102(34): 12189 - 12193. [Abstract] [Full Text] [PDF]

				S. J. Marx and W. F. Simonds Hereditary Hormone Excess: Genes, Molecular Pathways, and Syndromes Endocr. Rev., August 1, 2005; 26(5): 615 - 661. [Abstract] [Full Text] [PDF]

				A. Machens, M. Brauckhoff, H.-J. Holzhausen, P. N. Thanh, H. Lehnert, and H. Dralle Codon-Specific Development of Pheochromocytoma in Multiple Endocrine Neoplasia Type 2 J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3999 - 4003. [Abstract] [Full Text] [PDF]

				A. M. Dorward, K. L. Shultz, L. G. Horton, R. Li, G. A. Churchill, and W. G. Beamer Distal Chr 4 Harbors a Genetic Locus (Gct1) Fundamental for Spontaneous Ovarian Granulosa Cell Tumorigenesis in a Mouse Model Cancer Res., February 15, 2005; 65(4): 1259 - 1264. [Abstract] [Full Text] [PDF]

				G. Eisenhofer, S. R Bornstein, F. M Brouwers, N.-K. V Cheung, P. L Dahia, R. R de Krijger, T. J Giordano, L. A Greene, D. S Goldstein, H. Lehnert, et al. Malignant pheochromocytoma: current status and initiatives for future progress Endocr. Relat. Cancer, September 1, 2004; 11(3): 423 - 436. [Abstract] [Full Text] [PDF]

				A.-P. Gimenez-Roqueplo, J. Favier, P. Rustin, C. Rieubland, M. Crespin, V. Nau, P. K. Van Kien, P. Corvol, P.-F. Plouin, and X. Jeunemaitre Mutations in the SDHB Gene Are Associated with Extra-adrenal and/or Malignant Phaeochromocytomas Cancer Res., September 1, 2003; 63(17): 5615 - 5621. [Abstract] [Full Text] [PDF]

				D. J. Marsh, G. Theodosopoulos, K. Martin-Schulte, A.-L. Richardson, J. Philips, H.-D. Roher, L. Delbridge, and B. G. Robinson Genome-Wide Copy Number Imbalances Identified in Familial and Sporadic Medullary Thyroid Carcinoma J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1866 - 1872. [Abstract] [Full Text] [PDF]

				C. A. Koch, K. Pacak, and G. P. Chrousos The Molecular Pathogenesis of Hereditary and Sporadic Adrenocortical and Adrenomedullary Tumors J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5367 - 5384. [Abstract] [Full Text] [PDF]

				V. B. Wreesmann, R. A. Ghossein, S. G. Patel, C. P. Harris, E. A. Schnaser, A. R. Shaha, R. M. Tuttle, J. P. Shah, P. H. Rao, and B. Singh Genome-Wide Appraisal of Thyroid Cancer Progression Am. J. Pathol., November 1, 2002; 161(5): 1549 - 1556. [Abstract] [Full Text] [PDF]

				A.-P. Gimenez-Roqueplo, J. Favier, P. Rustin, C. Rieubland, V. Kerlan, P.-F. Plouin, A. Rotig, and X. Jeunemaitre Functional Consequences of a SDHB Gene Mutation in an Apparently Sporadic Pheochromocytoma J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4771 - 4774. [Abstract] [Full Text] [PDF]

				T. Dwight, A. E. Nelson, G. Theodosopoulos, A. L. Richardson, D. L. Learoyd, J. Philips, L. Delbridge, J. Zedenius, B. T. Teh, C. Larsson, et al. Independent Genetic Events Associated with the Development of Multiple Parathyroid Tumors in Patients with Primary Hyperparathyroidism Am. J. Pathol., October 1, 2002; 161(4): 1299 - 1306. [Abstract] [Full Text] [PDF]

				A. L. Young, B. E. Baysal, A. Deb, and W. F. Young Jr. Familial Malignant Catecholamine-Secreting Paraganglioma with Prolonged Survival Associated with Mutation in the Succinate Dehydrogenase B Gene J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4101 - 4105. [Abstract] [Full Text] [PDF]

				M. J. You, D. H. Castrillon, B. C. Bastian, R. C. O'Hagan, M. W. Bosenberg, R. Parsons, L. Chin, and R. A. DePinho Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice PNAS, January 24, 2002; (2002) 22632099. [Abstract] [Full Text] [PDF]

				M. J. You, D. H. Castrillon, B. C. Bastian, R. C. O'Hagan, M. W. Bosenberg, R. Parsons, L. Chin, and R. A. DePinho Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice PNAS, February 5, 2002; 99(3): 1455 - 1460. [Abstract] [Full Text] [PDF]